Jerome QUINONERO, PHD
DIRECTOR OF TOXICOLOGY & SAFETY PHARMACOLOGY
Jérôme has specialised in designing and conducting regulatory compliant safety pharmacology and toxicology programmes within the biopharmaceutical industry.
Over the last seventeen years he has successfully worked with small molecules, biologics, vaccines, cell therapies and drug delivery systems and has played a major role in advancing oncology, neurology and immunotherapy programmes through preclinical development up to phase I & II clinical trials. Jérôme is highly experienced in the selection and management of CROs for the conduct of regulatory or other studies, as well as in writing Investigators’ Brochures.
Jérôme is also an entrepreneur; in 1996 he co-founded Neurotech, a neurology and ophthalmology biotech company now based in the US, where he was pivotal in advancing France’s first cell therapy product into clinical trials.
Jérôme holds a PhD in Neuroscience from the Pierre & Marie Curie University, Paris.
Contact : Jérome QUINONERO